Call It Colonialism | Bloomberg’s War on Vaping Pt. 2

In part-2 of this RegWatch special series we are joined by Michelle Minton, a senior fellow at the Competitive Enterprise Institute in Washington, D.C. Hear why she thinks Bloomberg’s one size fits all policy is “insidious” and a throwback to the “colonialist origins of public health.”

2021-04-01
regulatorwatch.com

Study: Many Smokers Use Smokeless Tobacco Products to Cope With Smoking Areas’ Restrictions

The study titled, “Cigarette smokers’ concurrent use of smokeless tobacco: dual use patterns and nicotine exposure,” looked into the patterns of dual users’ product use and nicotine exposure on days when they used cigarettes exclusively (single use) versus days when they consumed both cigarettes and SLTs (dual use). Forty-six dual users (cigarettes and SLTs) recorded their product use behaviours in real time via ecological momentary assessment for a 2-week longitudinal design, answering questions related to situational factors (eg. location, mood) using this same diary. [...]

2021-04-01
vapingpost.com

Member states urged to do more to enforce new tobacco legislation

It is alleged that, despite the near year-old EU legislation, some tobacco companies have continued to launch extra menthol style products. The Tobacco Products Directive (TPD), applicable in EU member states, imposed a ban on flavoured tobacco products. The Directive includes measures on e-cigarettes, flavourings, additives and packaging. Cigarettes and RYO (roll your own) tobacco may no longer have flavours such as menthol, vanilla or candy that mask the taste and smell of tobacco. It is hoped the move will help deter young people from taking up smoking by banning cigarettes with a ‘characterising flavour’ other than tobacco.

2021-04-01
eureporter.co

ASU leads Arizona site for a clinical trial on smoking cessation drug

A plant-based medication may be the solution to nicotine and cigarette addiction, and an ASU professor is helping lead the study. Scott Leischow, director and professor at the College of Health Solutions, is heading the Arizona site for a clinical trial on the naturally occurring smoking cessation drug cytisinicline. According to Achieve Life Sciences CEO John Bencich, the Phase 3 ORCA-2 clinical trial is being run across 15 centers around the U.S. and the company hopes to enroll 750 participants in the 12-week trial. Leischow said people are paid up to $1,950 as compensation for participating in the study [...]

2021-04-01
statepress.com

Alabama House passes bill banning sales of e-cigarettes, vapes to people under 21

The Alabama House on Tuesday passed a bill that would ban the sales of e-cigarettes and vaping products to people under 21, the Alabama House Democratic Caucus said Wednesday. “There are certainly other changes and reforms that have been recommended that we strongly support, however this bill is a starting point which will result in greater accountability for manufacturers and retailers,” said state Rep. Barbara Drummond, D-Mobile, the main sponsor of the bill, HB273. “The simple truth is that these products are dangerous, highly addictive, and they are killing our young people.”

2021-04-01
al.com

Eight in 10 smoker parents worried about setting bad example for kids by smoking or vaping

Eight in 10 parents who smoke are worried about setting a bad precedent for their children by smoking or vaping, new research has found. Just under half of the 490 smokers polled say their children have now rumbled parents for their smoking or vaping habits and asked them to quit. The research by Swedish Match, producer of tobacco-free nicotine pouches ZYN, also revealed more than 41 per cent confess they have resorted to finding new ways to hide their habits in fear of being ticked off by their kids.

2021-04-01
thesun.co.uk